An MS treatment from Novartis cut by a third the rates of relapses compared to a standard treatment.
Back to Lifestyle
Lifestyle
October 23, 2026 at 4:47 PM
Novartis multiple sclerosis treatment cuts rates of relapse in pivotal trials
STAT News
Excerpt from STAT News.